I took a shot today, even though there was really very little compelling reason on the charts to do so (in my case, it was at the top of the channel/wedge connecting the highs from 12/8, 12/19 and 1/13 once it poked above $323, on hourly charts).
Bought a few of the Feb 27 315s at around $9.20......which probably means it's on its way to $350!
From my briefing ticker:
•Hearing suggestion that the decline was due to the co mentioning it is exiting the non-invasive prenatal test (NIPT) business; others saying the FY15 rev guidance was disappointing
Strange if it's the guidance though, as they guided Q4 revs of $512mm at the JPM Conference vs. $504mm estimates....of course, it's also recovered 11.5 points of the losses as I type this.